Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Pharmacology & Therapeutics|March 22, 2020
The tubal epigenome - An emerging target for ovarian cancerHunter D Reavis, Ronny DrapkinTrends in Cancer|August 19, 2020
Tumor Innervation: Cancer Has Some NerveHunter D Reavis, H Isaac Chen, Ronny DrapkinAnalytical Chemistry|July 22, 2016
Quantitative, Point-of-Care Immunoassay Platform to Guide and Monitor Sickle Cell Disease TherapyXiaoxi Yang, Hunter D Reavis, Christopher L Roberts, et al.Cell Death Discovery|March 14, 2018
NF-κB inhibition by dimethylaminoparthenolide radiosensitizes non-small-cell lung carcinoma by blocking DNA double-strand break repairPeter V Deraska, Colin O'Leary, Hunter D Reavis, et al.Cell Reports|March 3, 2021
MMB-FOXM1-driven premature mitosis is required for CHK1 inhibitor sensitivityTimothy B Branigan, David Kozono, Amy E Schade, et al.Communications Biology|December 12, 2022
L1CAM is required for early dissemination of fallopian tube carcinoma precursors to the ovaryKai Doberstein, Rebecca Spivak, Hunter D Reavis, et al.Cancer Research Communications|April 17, 2026
Alprazolam reduces inflammatory cytokine production in pancreatic cancer-associated fibroblastsHunter D Reavis, Aditi H Chaubey, Amanda L Smythers, et al.JCI Insight|January 25, 2024
Norepinephrine induces anoikis resistance in high-grade serous ovarian cancer precursor cellsHunter D Reavis, Stefan M Gysler, Grace B McKenney, et al.Biorxiv : the Preprint Server for Biology|June 4, 2026
A targetable opioid/cancer associated fibroblast axis drives extracellular matrix remodeling and tumor aggressiveness in pancreatic cancerKathryn E Maraszek, Arwen A Tisdale, Hunter D Reavis, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 15, 2019
The CHK1 Inhibitor Prexasertib Exhibits Monotherapy Activity in High-Grade Serous Ovarian Cancer Models and Sensitizes to PARP InhibitionKalindi Parmar, Bose S Kochupurakkal, Jean-Bernard Lazaro, et al.Pageof 1